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Clustered charge-to-alanine mutagenesis was performed on the large (L) polymerase protein of human respiratory
syncytial virus to identify charged residues in the L protein that are important for viral RNA synthesis and to generate
temperature-sensitive viruses. Clusters of three, four, and five charged residues throughout the entire L protein were
substituted with alanines. A minigenome replicon assay was used to determine the functions of the mutant L proteins and
to identify mutations that caused temperature sensitivity by comparing the level of reporter gene expression at 39 and 33°C.
Charge-to-alanine mutations were introduced into an antigenomic cDNA derived from RSV A2 strain to recover infectious
viruses. Of the 27 charge-to-alanine mutations, 17 recombinant viruses (63%) were obtained. Seven mutants (41%) exhibited
small plaque morphologies and/or temperature-sensitive growth in tissue culture. To generate mutant viruses with more
temperature-sensitive and attenuated phenotypes, several clusters of charge-to-alanine substitutions were combined. FiveINTRODUCTION
The large (L) protein of human respiratory syncytial
virus (hRSV), a pneumovirus of the Paramyxoviridae fam-
ily, is the viral RNA-dependent RNA polymerase (Lamb
and Kolakofsky, 2001; Collins et al., 2001). The L protein
is 2165 amino acids in length and is encoded by the L
gene that constitutes approximately 43% of the hRSV
genome (Stec et al., 1991). Comparative sequence align-
ments of the hRSV L protein with other RNA-dependent
RNA polymerases have identified conserved domains
(Poch et al., 1989, 1990; Sidhu et al., 1993). The L protein
most likely catalyzes initiation, elongation, and termina-
tion of RNA synthesis. Its large size suggests that it may
also perform other functions during RSV replication. As
with other negative-strand RNA viruses, the RSV genome
is fully encapsidated by the N proteins to form ribo-
nucleocapsids that serve as templates for RNA synthe-
sis. RSV viral RNA replication and mRNA synthesis occur
in the cytoplasm of the infected cells and require the
phosphoprotein (P) and the L protein (Grosfeld et al.,
1995; Yu et al., 1995). Recently, it has been shown that
two other RSV proteins also play important roles in RSV
RNA synthesis. The antitermination function of M2-1 is
essential for processive RNA synthesis and transcrip-
tional read-through at RSV gene junctions (Collins et al.,
1996; Hardy and Wertz, 1998; Fearns and Collins, 1999;
1207Tang et al., 2001). The M2-2 protein regulates the bal-
ance between RSV transcription and genome replication
(Jin et al., 2000; Bermingham and Collins, 1999).
hRSV is the leading viral cause of severe lower respi-
ratory tract infection in infants, young children, the el-
derly, and immunocompromised individuals worldwide.
Various approaches have been explored to develop RSV
vaccines for the prevention of disease associated with
RSV infection (reviewed by Collins et al., 1999; Falsey
and Walsh, 2000). Live attenuated RSV is considered the
most effective approach for RSV vaccine development.
Temperature-sensitive, live attenuated vaccine candi-
dates have been generated for several viruses that
cause human respiratory tract infections, such as influ-
enza virus (Belshe et al., 1998), hRSV (Wright et al., 2000),
and human parainfluenza virus (Hall et al., 1992; Karron
et al., 1995). Viruses with temperature sensitivity pheno-
types are able to replicate in the upper respiratory tract,
stimulating anti-viral immunity, but are restricted in the
lower respiratory tract, reducing the incidence of pneu-
monia and bronchiolitis. In the past, RSV ts mutants
generated by cold adaptation and/or random chemical
mutagenesis mostly mapped to the L gene, indicating
that the L protein is an important ts determinant (Juhasz
et al., 1997, 1999; Whitehead et al., 1998, 1999).
In order to identify charged residues that are important
for the function of the RSV L protein and to generate RSV
ts mutants, clustered charged residues in the RSV L
protein were substituted with alanines. Alanine-scanningcombination mutants were recovered that exhibited shut-
restricted replication in the respiratory tracts of cotton rat
To whom correspondence and reprint requests should be ad-
dressed. Fax: (650) 919-6610. E-mail: jinh@medimmune.com.
doi:10.1006/viro.2002.1596peratures ranging from 36 to 39°C in tissue culture and
002 Elsevier Science (USA)
mutagenesis has been proposed to minimize disruptionoff tem
s. © 20042-6822/02 $35.00
© 2002 Elsevier Science (USA)
All rights reserved.
in protein conformation that is likely to produce a protein
the function of which is only affected at a restricted
temperature (Wertman et al., 1992; Diamond and Kirkeg-
aard, 1994; Hassett and Condit, 1994; Parkin et al., 1996).
Introduction of multiple mutations in the L protein should
greatly increase the genetic stability of the virus ts phe-
notype. Thus, clusters of contiguous charged residues
ranging from three to five residues in the L gene of RSV
were selected as targets for mutagenesis. Within each of
these clusters, two to four charged residues were
changed to alanines. In addition, several single clustered
charge-to-alanine mutations were combined in a single L
protein to produce RSV that are more ts and attenuated.
Here, we also demonstrated that the minigenome repli-
con system is very useful for screening the function of
mutant L proteins in vitro and for identifying potential ts
mutations. In general, recombinant RSV could be recov-
ered from cDNA bearing L gene mutations that are not
lethal to its function as determined by the minigenome
assay. The phenotypes of recombinant RSV bearing
charge-to-alanine substitutions at single or multiple
charged clusters in the L gene are described.
RESULTS
Clustered charge-to-alanine mutagenesis
of the L gene
Site-directed mutagenesis was carried out in the RSV
L gene by changing clustered-charged amino acids to
alanines. A cluster was originally defined as a window of
five amino acids containing two or more charged resi-
dues (Wertman et al., 1992). In order to perform alanine-
scanning mutagenesis throughout the entire RSV L pro-
tein, only clusters containing three to five contiguous
charged residues were targeted. Two clusters of five, 2
clusters of four, and 18 clusters of three contiguous
charged residues are present in the RSV L gene. In each
of these clusters two to four of the charged residues
were substituted with alanines. In addition, a single Arg
residue at position 521, which is adjacent to the F520L
mutation in cpts530 (Juhasz et al., 1997), was also sub-
stituted by alanine. The positions of the charge-to-ala-
nine mutations in the L gene are listed in Table 1.
Functional analysis of the L protein mutants by RSV
minigenome assay
The effect of single clustered charge-to-alanine muta-
tions on RSV L protein function was determined by mini-
genome assays using chloramphenicol acetyltrans-
ferase (CAT) or Lac Z as a reporter gene. HEp-2 cells
infected with modified vaccinia virus Ankara (MVA) at 1
pfu/cell were transfected with plasmids pN, pP, and
pRSVCAT, or pRSVlacZ along with the wild-type (wt) or
mutant pL. Transfected cells were incubated at a per-
missive temperature of 33°C or at a nonpermissive tem-
perature of 39°C to determine whether the L protein
function was temperature sensitive. The relative activi-
ties of various L mutants are summarized in Fig.1.
The effect of alanine substitutions of the charged res-
idues on L polymerase function can be grouped into
different categories based on their relative levels of CAT
expression at 33 and 39°C. (1) Lethal mutations that
resulted in greater than 99% reduction in CAT expression
at 33°C: A9, A10, A13, A18, A20, A23, and A26. (2) Muta-
tions that had little or no effect on protein function at both
temperatures: A4, A5, A6, A7, A11, A14, A15, A21, and A24.
(3) Mutations that resulted in reduced L activity at both
temperatures: A1, A2, A3, A12, A22, A25, and AA8. (4)
Temperature-sensitive mutations that resulted in higher
levels of CAT expression at 33°C than at 39°C: A1, A12,
A16, A17, A19, and AA8; these L mutations have greater
potential to generate temperature-sensitive RSV mutants
when introduced into the virus. In addition, several mu-
tants, A3, A8, and A11, appeared to have a higher relative
activity at 39°C compared to that at 33°C.
TABLE 1
Substitutions of Charged Amino Acids with Alanines in RSV L
Mutations
Amino acid
positions
Sequence of
charged clustera
No. of substituted
residues
A1 520 R b 1
A2 1033–1034 DDR 2
A3 135–136 KEKDK 2
A4 1187–1188 RDKRE 2
A5 1725–1726 DKK 2
A6 1957–1958 RK 2
A7 146–148 DED 3
A8 255–256 HKE 2
A9 353–355 RKR 2
A10 435–437 DER 3
A11 568–569 EHEK 2
A12 587–588 LRDc 2
A13 620–621 KERE 2
A14 1025–1026 KDK 2
A15 1187–1190 RDKRE 4
A16 1208–1209 RER 2
A17 157–158 KDD 2
A18 348–349 EED 2
A19 510–511 ERD 2
A20 1269–1270 EKK 2
A21 1306–1307 KDE 2
A22 1378–1379 DED 2
A23 1515–1516 EKD 2
A24 1662–1663 KHK 2
A25 2043–2044 DKE 2
A26 2102–2103 HKH 2
AA8 588–589 RD 2
a Residues substituted with alanines are underlined.
b Substitution of single charged residue at position 520, adjacent to
F521L mutation in cpts530 (Juhasz et al., 1997).
c Inadvertent change of a noncharged leucine residue. The intended
changes are represented by AA8.
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L mutants that had no activity or altered activity in the
RSVCAT minigenome assay were further examined with
the RSVLacZ minigenome to determine whether their
activity could be enhanced by M2-1, since expression of
Lac Z was dependent on the processivity function of
M2-1. The RSVLacZ minigenome assay was performed
only at 33°C because the enzymatic activity of -galac-
tosidase is rapidly lost at 39°C. The A15 mutant that
showed a wild-type level of CAT expression at both 33
and 39°C was included for comparison. As shown in Fig.
2, the relative level of -galactosidase expressed by
each of the L mutants closely resembled that observed in
the RSVCAT minigenome assay. However, the levels of
-galactosidase expression were generally higher than
that observed for CAT expression, with the exception of
A19. L mutants that were nonfunctional by RSVCAT mini-
genome assay were also inactive in the RSVLacZ mini-
genome assay. Mutants A3, A22, and A25 had less than
10% of wt L activity in the CAT minigenome assay, but
their relative activity was much higher in the presence of
M2-1 as shown by the level of -galactosidase expres-
sion, suggesting that these L mutations might have af-
fected the processivity of the L protein.
Recovery of recombinant RSV with mutations in L
All the L mutations that did not completely abolish CAT
expression at 33°C were introduced into the L gene of a
full-length RSV antigenomic cDNA derived from the A2
strain to recover recombinant RSV mutants. Except for
mutants A2, A22, and A25, which had very low activity in
the RSVCAT minigenome assay, viruses were recovered
from the antigenomic cDNA bearing mutations that were
not lethal to the protein function as determined in vitro. A
total of 17 viruses was obtained, as indicated in Fig. 1.
Multiple attempts were also made to recover A18 and
A23, two representative lethal L mutations. As expected,
no viruses were recovered from cDNA bearing the A18 or
A23 mutations.
The recombinant viruses were plaque-purified and
amplified in Vero cells. Most of the mutants had a titer of
106–107 pfu/ml. The introduced mutations in the recom-
binant viruses were confirmed by sequence analysis of
the viral cDNA fragments obtained by RT–PCR using
pairs of primers spanning the mutated sites in the L
gene.
Temperature sensitivity of recovered RSV L mutants
The plaque-forming efficiency of the recombinant RSV
L mutants was initially evaluated at 33, 39, and 40°C in
HEp-2 cells. As indicated in Fig. 1, three mutants exhib-
ited the ts phenotype. rA2-A12 was ts at 38°C, while
rA2-A16 and rA2-AA8 had a shut-off temperature of 39°C.
In addition, several L mutants formed small plaques at
various temperatures. rA2-A1 formed smaller plaques at
39°C, but the small-plaque phenotype of rA2-A3 and
rA2-17 was detected only at 40°C. The small-plaque
phenotype of rA2-A7 and rA2-A19 was not dependent on
temperature; both had small-plaque morphology at 33°C.
rA2-AA8 also exhibited a small-plaque morphology at
33°C, in addition to a reduction in virus titer at 39°C.
rA2-12 had the lowest shut-off temperature among the
single clustered charge-to-alanine mutations showing a
virus titer reduction of 5.9 log10 pfu/ml at 38°C.
FIG. 1. Functional analysis of the L protein mutants by minigenome assay. HEp-2 cells were transfected with plasmids pN, pP, and pRSVCAT
together with wt or mutant pL in triplicates and incubated at 33 or 39°C for 36 h, and CAT protein expression was analyzed by ELISA. The levels of
CAT expression in each L-mutant-transfected cell are reported as relative to wt L (1.00). The relative activity of each mutant is an average from three
independent experiments. Infectious RSV recovered from L mutants is indicated as () and the converse by (). The plaque-forming efficiency of each
recovered virus was evaluated at 33, 39, and 40°C, and the temperatures at which different mutants exhibited altered plaque phenotypes are
indicated.
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Generation of RSV with multiple charged cluster-to-
alanine mutations
To generate hRSV with lower shut-off temperatures,
multiple mutations were introduced into the L gene by
combining single charged cluster mutations that gave
rise to altered virus phenotypes in tissue culture. A3, A7,
A15, and A16 were selected for combination to test the
functional importance of the two highly charged patches
(135–146 aa and 1187–1209 aa) in L. AA8 was also
incorporated into one of the combination mutants. Sev-
eral combination mutations were lethal to the L protein
function and did not result in virus recovery. Only five
recombinant viruses were obtained, and mutations intro-
duced into these combination mutants are listed in Table
2. The polymerase functions of the combination mutants
were analyzed by RSV minigenome assays for expres-
sion of CAT or Lac Z reporter gene (Fig. 3). A3 or A7 alone
did not show temperature sensitivity in the minigenome
assay, but a combination of these two mutations (C7)
resulted in an L protein that was ts for CAT expression at
39°C. Combining the AA8 mutation with C7 produced
C27 with greater reduced L function. A15 and A16 indi-
vidually displayed wt-like L activity at 33°C, but a com-
bination of these two mutations (C9) resulted in a protein
that was ts at 39°C, as shown by the RSVCAT minig-
enome assay. C22, a combination of A3 and A16 muta-
tions, had a level of activity similar to that of A3 at 33°C
but showed reduced activity at 39°C, as observed for
A16. C25 bearing C7 and C9 mutations at four different
charged clusters was still functional but exhibited a level
of activity lower than that of C7 or C9. All the L combi-
nation mutants also had a higher relative activity in the
RSVLacZ minigenome compared to that of the RSVCAT
minigenome at 33°C, indicating enhanced polymerase
activity in the presence of the M2-1 protein (Fig. 3).
FIG. 2. Comparison of relative activities of L mutants by RSVCAT and RSVLacZ minigenome assays. L mutants with reduced or no activity by
RSVCAT minigenome assay were compared to the relative activity obtained by the RSVLacZ minigenome assay in the presence of pM2–1. The assays
were performed at 33°C.
TABLE 2
Combined Clustered Charge-to-Alanine Mutations
Mutations Combined charged clusters
No. of
residues
changed
Single
charge-to-
alanine clusters
C7 135–136, 146–148 5 A3, A7
C9 1187–1190, 1208–1209 6 A15, A16
C22 135–136, 1208–1209 4 A3, A16
C25 135–136, 146–148, 1187–1190,
1208–1209
11 A3, A7, A15, A16
C27 135–136, 146–148, 588–589 7 A3, A7, AA8
FIG. 3. Functional analysis of combination L mutants by RSVCAT and
RSVLacZ minigenome assays. The RSVCAT minigenome assay was
performed at 33 and 39°C, whereas the pRSVLacZ minigenome assay
was performed only at 33°C. The relative activity of each L mutant is
shown.
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Phenotypes of combination L mutants
Recombinant viruses containing mutations at multiple
charged clusters were obtained from RSV antigenomic
cDNA bearing the following mutations: C7, C9, C22, C25,
and C27. These mutants exhibited altered plaque-form-
ing efficiencies in HEp-2 cells, and most of them showed
shut-off temperatures ranging from 36 to 38°C (Table 3).
With the exception of rA2-C7, which is not temperature
sensitive, the other four mutants were much more tem-
perature sensitive than viruses with individual charged
cluster mutations. Further combination of C7 with AA8
generated rA2-C27, which was ts at 37°C with reduced
plaque-size formation at 36°C. rA2-C25 exhibited the
cumulative effects of both rA2-C7 and rA2-C9. It was the
most ts combination mutant, with a shut-off temperature
at 36°C and reduced plaque size at 33°C in both HEp-2
and Vero cells.
Multiple-cycle growth analysis of the three combina-
tion mutants with shut-off temperatures between 36 and
38°C were examined in HEp-2 and Vero cells at 33 and
37°C (Fig 4). Consistent with their ts phenotypes, the
level of replication for rA2-C25 was more restricted than
those for rA2-C27 and rA2-C22 at 37°C. At 33°C, the
peak titers of these three mutants were similar to that of
wt rA2 in HEp-2 cells, although rA2-C25 showed a slower
growth rate. In Vero cells, rA2-C22 and rA2-C27 had
growth kinetics similar to that of wt rA2. However, rA2-
C25 had a slower rate of growth throughout the entire
5-day period. At 37°C, rA2-C25 did not replicate well in
both HEp-2 and Vero cells, showing a peak titer reduc-
tion of approximately 5.2 log10 in Vero cells. The peak titer
of rA2-C27 was reduced by approximately 1.5 log10 in
both HEp-2 and Vero cells. rA2-C22 had a growth rate
similar to that of the wt rA2 in both cell lines.
Replication of the combination ts mutants was evalu-
ated in respiratory tracts of cotton rats (Table 3). Consis-
tent with the phenotypes observed in tissue culture, the
four combination L mutants had restricted replication in
the lower respiratory tract of cotton rats. Several individ-
ual, clustered charge-to-alanine mutants were also
tested in cotton rats. As shown in Table 3, rA2-A16 was
ts at 39°C in HEp-2 cells, but it replicated as efficiently as
wt rA2 in cotton rats. However, rA2-C9 containing A15
and A16 mutations had a reduction of 2.5 log10 compared
to rA2 in the lungs of cotton rats.
DISCUSSION
In this report clustered charge-to-alanine mutagenesis
of the RSV L polymerase protein was used to generate
temperature-sensitive viruses. Substitutions at 27 indi-
vidual charged clusters by alanines in the RSV L protein
generated 17 recombinant viruses (63%). Seven mutants
(41%) exhibited ts and/or small plaque phenotypes in
tissue culture. Several mutants with more ts and atten-
uated phenotypes were produced by the introduction of
multiple clustered charge-to-alanine mutations in the L
protein. To our knowledge, this is the first report to
describe the generation of RSV ts mutants by clustered
charge-to-alanine mutagenesis of the RSV L protein. A
similar approach has been used to generate ts mutants
for polioviruses (Diamond and Kirkegaard, 1994), influ-
enza A viruses (Parkin et al., 1996), vaccinia viruses
(Hassett and Condit, 1994), and Dengue virus (Hanley et
al., 2002). Alanine substitutions of charged amino acids
have also yielded temperature-sensitive L polymerases
of Sendai virus with defects in viral RNA transcription
and replication in vitro (Feller et al., 2000a).
Minigenome replicon assays have been demonstrated
to be very useful in analyzing the functions of viral pro-
teins involved in RNA synthesis and in identifying poten-
tial ts mutations (Marriott et al., 1999; Feller et al., 2000b;
Lu et al., 2002). Seven of the 27 clustered charge-to-
alanine L proteins that were not functional by the mini-
genome assay also failed to produce infectious RSV. It
was also difficult to recover infectious viruses that ex-
hibited a very low level of activity in vitro, such as the A2,
A22, and A25 mutations. Potential ts mutations can be
identified by comparing L protein activity at 33°C with
that at 39°C. For example, A12 and A16 showed greatly
reduced activity at 39°C compared to 33°C in vitro, and
the recovered mutants bearing these mutations were
also ts at 38 and 39°C, respectively. Mutant L protein
with reduced in vitro activities correlated well with the
altered virus phenotypes. However, the minigenome as-
say is not completely predictive of virus phenotypes.
TABLE 3
Replication of L Mutants in HEp-2 Cells and in Cotton Rats
RSV L
mutants 33°C 36°C 37°C 38°C 39°C
Replication in lungs
of cotton rats
(mean log10
pfu/g  SE)a
rA2-A3 7.26 ND ND ND 6.88 ND
rA2-A7 7.00b ND ND ND 6.30 4.90  0.10
rA2-A15 6.00 ND ND ND 6.47 ND
rA2-A16 6.78 6.74 6.30 6.30 — 4.90  0.10
rA2-AA8 6.08b 6.08b 6.08b 5.78b — 1.53  1.23
rA2-C7 5.48b 5.74b 5.53b 5.30b 5.51b ND
rA2-C9 5.80 5.57 5.49 — — 2.29  0.91
rA2-C22 7.04 7.11b 7.11b — — 1.7
rA2-C25 6.45b — — — — 1.7
rA2-C27 6.90 5.96b — — — 1.7
wt rA2 7.00 6.94 6.94 6.70 6.70 4.80  0.27
Note. —, Plaques not visible to the naked eye after immunostaining.
a Cotton rats were infected with 106 pfu of RSV intranasally. Four days
postinfection, lung tissues were homogenized and titrated on Vero
cells.
b Plaque size reduction of 50–80% relative to wt rA2.
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Discrepancies between the in vitro activity of the mutant
L protein and the virus phenotype were observed for
several charge-to-alanine mutations. For example, A7 did
not show reduced activity in vitro, but rA2-A7 formed
small plaques even at the permissive temperature. The
A19 L mutant was ts in vitro, but rA2-A19 was not ts;
instead it exhibited small-plaque morphology at 33oC.
Interestingly, several L mutants showed higher activity at
39oC than at 33oC. With the exception of rA2-A3, which
exhibited reduced plaque size at 40°C, these mutations
did not result in any observable changes in plaque-
forming efficiency at the permissive and nonpermissive
temperatures.
The RSVLacZ minigenome was also used to test the
functions of the L mutants. Overall, the relative polymer-
ase activity was higher using the RSVLacZ minigenome
that is dependent on the processivity function of M2-1
(Tang et al., 2001). None of the L mutants showed spe-
cific defects in M2-1-mediated processive RNA synthe-
sis. The activity of A3 was relatively more enhanced by
M2-1 compared to the other L mutations tested, suggest-
ing that the A3 mutation may have affected the proces-
sivity of the L protein.
Charged residues that are important for L polymerase
function can be identified by the clustered charge-to-
alanine mutagenesis. Sequence alignment showed that
six regions, designated domain I to VI, are highly con-
served among 10 different paramyxovirus L proteins
(Sidhu et al., 1993). Although specific functions have yet
to be assigned to each of these domains, mutagenesis of
conserved residues in domains I to VI of Sendai virus L
protein revealed that many of these residues are impor-
tant for polymerase function (Chandrika et al., 1995;
Smallwood et al., 1999; Feller et al., 2000a; Cortese et al.,
2000). The highly conserved GDNQ motif (Poch et al.,
1989), the putative site of phosphodiester bond forma-
FIG. 4.Multiple-cycle growth curves of combination L mutants analyzed in Vero and HEp-2 cells. Cells were infected at a m.o.i. of 0.1 and incubated
at 33 or 37°C. Aliquots of culture medium were collected at 24-h intervals and virus titers were determined by plaque assay on Vero cells.
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tion, is located in domain III (Schnell and Conzelmann,
1995; Sleat and Banerjee, 1993). Alignment of hRSV L
with other paramyxovirus L protein sequences indicates
that the A13 mutation is located in the putative RNA
binding domain (Poch et al., 1990). The A13 mutation is
coincidentally located at the same position as mutant 2-2
of Sendai virus L protein, which was also inactive for
RNA synthesis (Smallwood et al., 1999). A20 is located in
a highly conserved charged region in domain V of
paramyxovirus L protein. An analogous mutation in Sen-
dai virus L (SS21) was also completely inactive for RNA
replication in vitro (Cortese et al., 2000). This suggests
that functionally important residues identified in one
paramyxovirus L protein may also be important in a
different paramyxovirus polymerase even when the vi-
ruses are distantly related (Feller et al., 2000b). This was
also demonstrated by the importation of the F521L mu-
tation present in the L protein of RSV strain cpts530 into
human parainfluenza virus type 3 strain cp45, which
resulted in increased attenuation of cp45 (Skiadopoulos
et al., 1999). cpts530 has a shut-off temperature at 39°C
in tissue culture (Juhasz et al., 1997). Mutations of the
charged residues in linear proximity to F521, such as
E511AR512A (A19) and R520 (A1), also rendered the L
protein sensitive to temperature in vitro, and the cognate
viruses formed small plaques at 33 and 39°C, respec-
tively. This result further indicates the importance of the
regions adjacent to the 521 residue for L protein function
and virus replication.
Only two clusters of five contiguous charged residues
are found in the L protein at residues 134–138 and
1186–1190. Alanine substitutions of two charged resi-
dues in the first cluster reduced L protein activity in vitro,
and the recombinant virus rA2-A3 exhibited small-plaque
morphology at 40oC. Substitution of two (A4) or four
amino acids (A15) in the second cluster had no effect on
L protein function in vitro. When additional mutations
were engineered around these charged clusters, the
resulting viruses rA2-C7 and rA2-C9 showed altered vi-
rus replication in tissue culture. Combination of the C7
and C9 mutations produced a very attenuated virus,
rA2-C25, which had a very low shut-off temperature at
36°C. Thus, incrementally more attenuated and temper-
ature-sensitive RSV could be generated by successive
introduction of mutations at multiple charged clusters in
the L protein.
Recombinant RSV ts mutants with clustered charge-
to-alanine mutations possess characteristics that are
particularly attractive for the development of live attenu-
ated vaccines. In the past, RSV ts mutants could only be
obtained by cold passage and/or chemical mutagenesis
making it difficult to control the level of virus attenuation.
Using reverse genetics, it is now feasible to introduce
mutations into the RSV genome to fine-tune and obtain
the desired level of attenuation. The ts mutations identi-
fied in the L polymerase protein can also be utilized to
attenuate other RSV strains such as subgroup B chimeric
RSV (Cheng et al., 2001). Since the ts phenotype is
usually specified by three or more nucleotide changes in
the L protein, the recombinant virus will be less prone to
phenotypic reversions. The usefulness of L ts mutants for
RSV vaccine development is currently being evaluated.
MATERIALS AND METHODS
Cells and viruses
Monolayer cultures of HEp-2 and Vero cells were
maintained in DMEM supplemented with 10% fetal bo-
vine serum. Modified vaccinia virus Ankara expressing
bacteriophage T7 RNA polymerase (MVA-T7) was pro-
vided by Dr. Bernard Moss (Sutter et al., 1995; Wyatt et
al., 1995) and propagated in CEK cells (SPAFAS). Recom-
binant A2 RSV was grown in Vero cells as described
previously (Jin et al., 1998).
Mutagenesis of the RSV L gene and functional
analysis of the mutant L proteins
The L gene expression plasmid (pL) was engineered
under the control of the T7 promoter as described by Jin
et al. (1998). Mutations were introduced into pL by pairs
of mutagenic primers using the QuikChange Site-Di-
rected Mutagenesis Kit (Stratagene). The introduced mu-
tations were verified by DNA sequence analysis. The
entire L gene cDNA of two select mutants was se-
quenced and no unintended mutations were identified,
suggesting that the pfu polymerase used for mutagene-
sis had very high fidelity and was unlikely to introduce
spurious mutations during the mutagenesis reaction.
The positions of the charged residues that were changed
to alanines are listed in Table 1.
The functions of the mutant L proteins were analyzed
for their ability to support transcription and replication of
a RSV minigenome, pRSVCAT or pRSVLacZ, that en-
coded the chloramphenicol acetyltransferase or -galac-
tosidase (lacZ) gene in the negative-sense under the
control of the T7 promoter as described previously (Tang
et al., 2001). The protein expression plasmids encoding
the RSV N or P proteins under the control of the T7
promoter have been described previously (Jin et al.,
1998). Subconfluent HEp-2 cells were infected with
MVA-T7 at a multiplicity of infection (m.o.i.) of 1 pfu/cell,
followed by transfection with 0.2 g of pN, 0.2 g of pP,
and 0.1 g of wt or mutant pL, together with 0.1 g of
pRSVCAT or 0.2 g of pRSVLacZ. pM2-1 (0.3 g) also
was included in the pRSVLacZ transfections. Each trans-
fection reaction was performed in duplicate using Lipo-
fecTACE (Invitrogen) according to manufacturer’s proto-
cols. The transfected cells were incubated at 33 or 39°C
for 36 h, and the level of reporter gene expression was
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measured. The levels of CAT protein expression were
determined using an ELISA kit (Roche Molecular Bio-
chemicals). The -galactosidase protein expression was
measured by monitoring the change in optical density at
550 nm (OD550) following incubation of the cell extract
with chlorophenol red--D-galactopyranosidase (Roche
Molecular Biochemicals) as described by Tang et al.
(2001). The levels of the reporter gene expressed by the
L mutants are expressed relative to that of wt L.
Recovery of recombinant RSV bearing mutations in
the L gene
The L gene with the engineered mutations was ex-
cised from pL through the unique BamHI and NotI re-
striction sites and introduced into pRSVC4G that con-
tained a C to G change at the fourth position of the RSV
leader in the antigenomic sense (Jin et al., 1998). All the
L mutations introduced into the full-length antigenomic
cDNA clones were confirmed by DNA sequencing.
Recovery of recombinant RSV was performed as de-
scribed previously (Collins et al., 1995; Jin et al., 1998).
Subconfluent HEp-2 cells were infected with MVA-T7 at 1
pfu/cell and transfected with 0.4 g pN, 0.4 g pP, 0.2 g
mutant pL, and 0.4 g of antigenomic cDNA containing
the corresponding mutations engineered in the L gene.
Following transfection, cells were incubated at 33°C for
3 days and the cell culture supernatants were used to
infect fresh Vero cells to amplify rescued virus. Trans-
fections that did not result in virus recovery were re-
peated in the presence of wt pL, and the mutants were
plaque isolated. Individual plaques were subsequently
screened for the introduced mutations in the L gene. All
of the mutations introduced into the recombinant RSV
mutants were confirmed by sequence analysis of the
RT–PCR cDNA fragments spanning the introduced mu-
tation sites in the L gene. Recombinant viruses were
grown in Vero cells and titrated by plaque assay on Vero
cells.
Determination of temperature sensitivity of
recombinant mutants
Temperature sensitivity of the recovered recombinant
viruses was examined by plaque assay on Vero or HEp-2
cells at temperatures ranging from 33 to 40°C. Monolay-
ers of HEp-2 or Vero cells were infected with 10-fold
serially diluted virus and overlaid with L15 medium con-
taining 1% methylcellulose and 2% fetal bovine serum.
The infected cells were incubated for 6 days at 33°C in
a CO2 incubator or in water-tight containers containing
5% CO2 submerged in circulating water baths. The cir-
culating thermoregulators were calibrated to 38, 39, or
40°C and maintained the set temperatures to within
0.1°C. After 6 days of incubation, plaques were enumer-
ated following immunostaining. The shut-off temperature
was defined as the lowest temperature that had a titer
reduction of 100-fold or greater compared to that at 33°C.
Growth kinetics of RSV L mutants in cell culture
Subconfluent HEp-2 and Vero cells were used for
multiple-cycle growth analyses of the RSV L mutants.
Cell monolayers in 6-cm dishes were infected with virus
at a m.o.i. of 0.1. After adsorption for 1 h at room temper-
ature, the infected cells were washed twice with PBS,
overlaid with 2 ml of OptiMEM, and incubated at 33 or
37°C. At 24-h intervals, 180 l of culture supernatant was
removed, stabilized with 0.2 M sucrose, 3.8 mM KH2PO4,
7.2 mM K2PO4, and 5.4 mM monosodium glutamate
(SPG), and stored at 80°C prior to titration. Virus titers
were determined by plaque assay on Vero cells.
Replication of RSV L mutants in cotton rats
The replication of RSV L mutants was compared with
that of wt rA2 in 4- to 6-week-old cotton rats (Sigmodon
hispidus) that were free of respiratory pathogens.
Groups of five cotton rats were inoculated with 106 pfu of
virus in 0.1 ml intranasally under light methoxyflurane
anesthesia. Four days after infection, cotton rats were
sacrificed by CO2 asphyxiation and lungs were homog-
enized in 2 ml of OptiMEM I. Virus titers were determined
by plaque assay on Vero cells and expressed as pfu per
gram of tissue (Prince et al., 1978; Crowe et al., 1994).
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